ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Schizophrenia
Cognitive Behavioral Therapy Combined with Aripiprazole in the Treatment of Schizophrenia: Effects on Cognitive Function and Psychological State
Provisionally accepted
- Liupanshui Shuikuang Hospital, Liupanshui, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective The aim of this study is to assess the effects of cognitive behavioral therapy (CBT) combined with aripiprazole on clinical symptoms, cognitive function, and emotional state in patients with schizophrenia. Methods A single-center retrospective controlled design was used, with data from the electronic medical records of the psychiatry department of Liupanshui Shuikuang hospital. A total of 168 patients were included and divided into two groups based on whether they received structured CBT intervention: the combined treatment group (aripiprazole + CBT) and the monotherapy group (aripiprazole only), with 84 patients in each group. Propensity score matching was used to reduce bias, and the clinical symptoms, cognitive function, and emotional state of patients were evaluated at baseline (T0), 3 months (T1), and 6 months (T2). Results The combined treatment group showed significant improvements in Positive and Negative Syndrome Scale (PANSS) total score, Montreal Cognitive Assessment (MoCA) score, Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder 7 (GAD-7) compared to the monotherapy group (P < 0.05). In terms of quality of life, the combined treatment group showed significantly greater improvement in Schizophrenia Quality of Life Scale (SQLS) total score compared to the monotherapy group (P = 0.006). Multivariate regression analysis revealed that CBT combined treatment significantly enhanced the improvement in PANSS total score and MoCA score, and was associated with reductions in depression and anxiety symptoms. An increase in treatment frequency and intensity further enhanced efficacy. Subgroup analysis showed better treatment responses in younger patients and those with a shorter disease duration. Conclusion CBT combined with aripiprazole significantly improves the psychiatric symptoms, cognitive function, and emotional state of patients with schizophrenia, and the frequency and intensity of treatment have a positive impact on efficacy.
Keywords: aripiprazole, ClinicalSymptoms, cognitive behavioral therapy, Cognitive Function, emotional state, Quality of Life, Schizophrenia
Received: 29 Dec 2025; Accepted: 09 Feb 2026.
Copyright: © 2026 Dong, Jiang, Guo, Dai, Jiao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Neng Dong
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.